Evidence-based recommendations on rapid tests for group A streptococcal (strep A) infections in people aged 5 and over with a sore throat
Evidence-based recommendations on point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast
Evidence-based recommendations on rucaparib (Rubraca) for relapsed platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer that has responded to
Formally endorses resources produced by external organisations that support the implementation of NICE guidance and the use of quality standards.
Find out more about quality standards advisory committee 3 members at NICE.
Find out more about the NICE Medical Technologies Advisory Committee members by reading their biographies. Professor Peter Groves Chair About
Everything NICE has said on preventing, detecting and managing acute kidney injury in an interactive flowchart
Everything NICE has said on recognising and managing ovarian cancer in an interactive flowchart
Everything NICE has said on urogenital conditions in an interactive flowchart
Everything NICE has said on reducing the risk of excess winter deaths and illness associated with cold homes in an interactive flowchart
Everything NICE has said on antibiotic prescribing for self-limiting respiratory tract and ear infections in primary care in an interactive flowchart
This agreement relates to: Tezacaftor and ivacaftor (Symkevi®) in combination with ivacaftor (kalydeco) for treating cystic fibrosis patients who are
As a public body, NICE is required to follow civil service principles on communicating during the lead up to the general election.
Our tool to help you plan for and implement NICE guidance. View upcoming guidance and understand the impact of guidance on your resources. Previously known as the forward planner.
NICE recommendations on the use of highly specialised technologies are made by an independent advisory committee called the Highly Specialised...
Outside interests of the NICE board
Patient access schemes and the NICE Patient Access Liaison Unit When assessing new drugs and treatments, NICE looks at the cost of the treatment and...
We've produced resources to support our social care guidelines and quality standards. The resources contain key messages and are designed to help you...
Everything NICE has said on cannabis-based medicinal products in an interactive flowchart.
Everything NICE has said on multiple sclerosis in an interactive flowchart
This guideline covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.
This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for adults with multiple sclerosis by promoting symptom management, comprehensive reviews and effective relapse treatment.
Scientific advice for developers of pharmaceuticals
Recommendation ID NG140/7 Question What is the optimal regimen for general anaesthesia for women having surgical abortion? Any explanatory
Recommendation ID NG140/5 Question What local anaesthetic techniques are most effective for women having surgical abortion? Any explanatory
Recommendation ID NG140/1 Question What is the optimal antibiotic prophylaxis regimen for women who are having a surgical abortion?
Recommendation ID NG140/2 Question What are the most effective and acceptable methods of cervical priming before dilatation and evacuation
Recommendation ID NG140/4 Question For women who are having medical abortion between 10+1 and 12+0 weeks, what is the efficacy and acceptability
Recommendation ID NG140/3 Question Should women having a surgical abortion up to and including 10+0 weeks' gestation have anti-D prophylaxis
Recommendation ID NG33/2 Question Apart from culture, what other diagnostic tests or combinations of tests are effective inestablishing
Recommendation ID NG33/4 Question What effects does isolation have on the quality of life of people being treated for TB? Any explanatory
Recommendation ID NG140/6 Question What is the effectiveness and safety of regimens using mifepristone and misoprostol for women who are
Recommendation ID NG136/6 Question Which people with extreme hypertension (220/120 mmHg or higher) or emergency symptoms should be referred
Recommendation ID NG137/1 Question What is the most accurate prenatal screening marker for TAPS, including middle cerebral artery peak systolic
Recommendation ID NG33/3 Question For isoniazid-resistant TB, what is the most effective regimen for reducing mortality andmorbidity?
Recommendation ID NG33/5 Question For people with active, drug susceptible TB who experience treatment interruptions because of adverse
Recommendation ID NG33/1 Question In people with suspected TB, what is the relative clinical and cost effectiveness of universal andrisk-based
Recommendation ID TA599/1 Question The committee noted that there was no clinical evidence showing that having sodium zirconium cyclosilicate
A quick and easy-to-read guide to the standard of care you should expect from a home care provider.
A quick guide for home care managers on preventing deaths and illnesses associated with cold homes.
NICE quick guide - moving between hospital and home, including care homes
A quick guide for care home managers Jump to: Risk factors Recognising delirium Preventing delirium Sharing information Further information
Data on the recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.
Data on the cancer recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.
Everything NICE has said on managing skin conditions and skin damage in an interactive flowchart
The following NICE published diagnostics assessments have been transferred to the static list. Guidance is moved to the static list following...